MedPath

Efficacy/Safety of Lansoprazole in Patients With Frequent Heartburn

Phase 3
Completed
Conditions
Heartburn
Registration Number
NCT00389948
Lead Sponsor
Novartis
Brief Summary

Heartburn, a burning sensation in the chest or throat, occurs in many patients when acidic stomach contents move into the esophagus from the stomach. This study will investigate the safety and efficacy of lansoprazole 15 mg once a day in treating frequent heartburn.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
576
Inclusion Criteria
  1. Experiencing heartburn at least 2 days per week over the past month.
  2. Having heartburn that responds to heartburn medication.
  3. Be willing to discontinue the use of heartburn treatment for 7 days prior to inclusion in the study.
Exclusion Criteria
  1. Having history of erosive esophagitis or gastroesophageal reflux disease diagnosed by a physician and confirmed by testing (endoscopy).
  2. Be unwilling to take only the study medication, and antacid provided as a rescue medication for relief of acute heartburn during the study.

Other protocol-defined inclusion or exclusion criteria may apply

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
To demonstrate that repeated daily doses of 15 mg of lansoprazole are effective in increasing the proportion of days with no heartburn during study treatment, when compared to placebo.
Secondary Outcome Measures
NameTimeMethod
To determine the proportion of nighttimes with no heartburn during 14 days of treatment in subjects receiving lansoprazole versus placebo
To determine the proportion of subjects with no heartburn during day 1 in those receiving lansoprazole versus placebo
Evaluation of lansoprazole safety.

Trial Locations

Locations (22)

Clinical Research Consultants Inc.

🇺🇸

Hoover, Alabama, United States

Radiant Research

🇺🇸

Lakewood, Washington, United States

California Bio Medical Research Institute

🇺🇸

Los Angeles, California, United States

Allergy Medical Group of North Area

🇺🇸

Roseville, California, United States

Eastern Research

🇺🇸

Hialeah, Florida, United States

Health Awareness Inc.

🇺🇸

Jupiter, Florida, United States

Miami Research Associates

🇺🇸

Miami, Florida, United States

Clinical Associates

🇺🇸

Reisterstown, Maryland, United States

Medex Healthcare Research, Inc.

🇺🇸

St. Louis, Missouri, United States

Meridian Clinical Research LLC

🇺🇸

Omaha, Nebraska, United States

Scroll for more (12 remaining)
Clinical Research Consultants Inc.
🇺🇸Hoover, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.